Elagolix

Trade Name:

Orilissa

Manufacturer/Distributor:

AbbVie

abbvie.ca

Classification:

Gonadotropin releasing hormone receptor antagonist

ATC Class:

G03XA - antigonadotropins and similar agents

Status:

active

Notice of Compliance (yyyy/mm/dd):

2018/10/05

Date Marketed in Canada (yyyy/mm/dd):

2018/10/31

Presentation:

Tablet: 150 mg. DIN: 02481332

Tablet: 200 mg. DIN: 02481340

Comments:

For treatment of moderate to severe pain associated with endometriosis.

Source:

Letter from company

Keywords:

elagolix

Keywords:

endometriosis

Access:

public

Back to:

Please note - this is not a complete list of products available in Canada. For a complete list of drug products marketed in Canada, visit the Health Canada Drug Product Database

A (37) | B (20) | C (24) | D (37) | E (40) | F (12) | G (11) | H (9) | I (24) | K (1) | L (26) | M (12) | N (7) | O (12) | P (28) | R (14) | S (27) | T (33) | U (4) | V (13) | W (2) | Z (4)

Generic Name	Common Trade Name(s)	Classification	Date Marketed in Canada (yyyy/mm/dd)
Semaglutide	Ozempic	Incretin mimetic	2018/02/22
Semaglutide	Rybelsus	Incretin mimetic	2020/04/19
Sibutramine	Meridia		2010/10/08
Sildenafil citrate	Revatio IV	cGMP-Specific Phosphodiesterase Type 5 Inhibitor	2010/08/31
Silodosin	Rapaflo	Alpha-1 adrenergic blocker	2012/03/05
Siltuximab	Sylvant	Immunosuppressive agent	2015/01/02
Siponimod	Mayzent	Immunomodulatory agent	2020/04/24
Sitagliptin	Januvia	Hypoglycemic agent	2012/11/20
Sitagliptin and metformin	Janumet	Hypoglycemic agent	2009/09/24
Sitaxsentan	Thelin	Endothelin receptor antagonist
Sodium zirconium cyclosilicate	Lokelma	Potassium binder	2019/10/17
Sofosbuvir + velpatasvir	Epclusa	Antiviral agent	2016/07/11
Sofosbuvir + velpatasvir + voxilaprevir	Vosevi	Antiviral agent for treatment of chronic hepatitis C infection	2017/09/18
Sonidegib	Odomzo	Antineoplastic agent	2020/06/11
Stiripentol	Diacomit	Antiepileptic	2014/12/21
Sumatriptan + naproxen	Suvexx	Serotonin receptor agonist + NSAID	2020/07/24
Suvorexant	Belsomra	Hypnotic	2019/04/16
Tadalafil	Adcirca	cGMP-specific phosphodiesterase type 5 inhibitor	2009/11/25
Tafamidis	Vyndaqel	Selective stabilizer of transthyretin - cardiac drug	2020/04/07
Tamsulosin + dutasteride	Jalyn	Alpha-1 blocker + 5-Alpha reductase inhibitor	2012/02/03
Tapentadol	Nucynta CR	Opioid analgesic	2011/03/01
Tapentadol	Nucynta IR	Opioid analgesic	2012/03
Tedizolid	Sivextro	Oxazolidinone antibiotic	2015/10/08
Telaprevir	Incivek	Antiviral agent	2011/10/06
Telmisartan + amlodipine	Twynsta	Angiotensin II antagonists and calcium channel blockers	2011/08/03
Telotristat ethyl	Xermelo	Tryptophan hydroxylase inhibitor	2018/10/12
Tenapanor	Ibsrela	Sodium/hydrogen exchanger inhibitor	2020/11/23
Tepotinib	Tepmetko	Protein kinase inibitor (antineoplastic agent)
Teriflunomide	Aubagio	Immunomodulator agent	2013/11/15
Teriparatide	Osnuvo	Bone formation agent	2020/10/27
Testosterone	Natesto	Androgen	2016/05/06
Tetracaine	Pontocaine (spinal anesthesia)	Local anesthetic
Thalidomide	Thalomid	Immunomodulatory agent	2010/08/06
Tibolone	Tibella	Hormone replacement therapy	2020/07/29
Ticagrelor	Brilinta	Platelet aggregation inhibitor	2011/06/01
Tiotropium + olodaterol	Inspiolto Respimat	Bronchodilator combination - LAMA plus LABA	2015/05/29